Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
97
NCT01595997
Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 29, 2012
Completion: Oct 31, 2012
NCT01624376
Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease
Phase: Phase 2
Start: Jun 30, 2012
Completion: Aug 31, 2013
NCT01936337
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
Start: Aug 31, 2013
Completion: Jul 31, 2014